Grand Pharmaceutical Group Ltd banner
G

Grand Pharmaceutical Group Ltd
HKEX:512

Watchlist Manager
Grand Pharmaceutical Group Ltd
HKEX:512
Watchlist
Price: 7.52 HKD -0.4% Market Closed
Market Cap: HK$26.7B

Balance Sheet

Balance Sheet Decomposition
Grand Pharmaceutical Group Ltd

Balance Sheet
Grand Pharmaceutical Group Ltd

Rotate your device to view
Balance Sheet
Currency: HKD
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
91
70
44
56
48
59
67
38
60
307
343
305
250
460
654
484
641
912
1 059
1 837
1 753
1 444
1 340
1 341
Cash
0
0
0
0
0
0
0
38
60
307
343
305
250
460
654
484
641
912
1 059
1 837
1 753
1 444
1 340
1 341
Cash Equivalents
91
70
44
56
48
59
67
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Short-Term Investments
39
41
50
35
8
11
0
0
0
0
0
0
0
50
1
11
18
46
72
521
1 113
1 039
773
1 438
Total Receivables
22
17
17
8
8
8
8
65
86
246
349
458
926
1 005
1 082
1 310
1 348
1 362
1 555
1 716
2 149
2 207
2 686
3 285
Accounts Receivables
22
17
17
8
8
6
10
58
77
140
197
209
322
350
466
697
908
929
898
815
968
1 094
958
1 157
Other Receivables
0
0
0
0
0
2
2
7
9
106
152
249
604
656
617
613
440
433
657
901
1 182
1 113
1 728
2 128
Inventory
11
8
5
4
4
4
8
64
55
216
319
442
562
517
622
636
763
770
814
955
1 117
1 340
1 389
1 371
Other Current Assets
14
1
0
0
0
14
0
10
6
59
76
34
134
101
47
39
178
339
316
290
646
857
829
591
Total Current Assets
176
137
116
103
68
96
84
177
207
829
1 087
1 240
1 872
2 133
2 406
2 481
2 947
3 429
3 816
5 319
6 779
6 887
7 016
8 026
PP&E Net
192
197
154
89
33
33
35
132
138
451
726
1 423
2 109
2 291
2 543
2 644
2 892
2 876
3 264
3 410
3 802
3 942
3 986
4 266
PP&E Gross
192
197
154
89
33
33
35
132
138
451
726
1 423
2 109
2 291
2 543
2 644
2 892
2 876
3 264
3 410
3 802
3 942
3 986
4 266
Accumulated Depreciation
221
204
177
219
131
136
145
6
17
47
87
150
161
241
401
542
794
932
1 366
1 641
1 910
2 057
2 264
2 554
Intangible Assets
0
55
130
71
13
12
0
2
1
1
1
0
83
68
651
796
876
816
795
882
1 010
1 398
1 657
2 083
Goodwill
0
0
0
0
2
1
0
0
0
55
72
97
125
125
381
481
512
488
480
506
597
644
589
1 300
Note Receivable
0
0
0
0
0
0
0
0
0
0
17
37
20
0
14
0
0
0
0
114
0
0
0
0
Long-Term Investments
7
5
14
8
76
75
75
58
66
40
60
64
50
46
322
371
439
5 481
5 341
6 437
8 380
8 447
8 398
8 213
Other Long-Term Assets
2
0
0
0
4
4
4
201
196
311
468
492
307
305
316
368
397
407
117
317
491
1 054
870
1 104
Other Assets
0
0
0
0
2
1
0
0
0
55
72
97
125
125
381
481
512
488
480
506
597
644
589
1 300
Total Assets
377
N/A
394
+5%
414
+5%
270
-35%
197
-27%
220
+12%
199
-10%
570
+186%
609
+7%
1 687
+177%
2 431
+44%
3 354
+38%
4 565
+36%
4 991
+9%
6 633
+33%
7 142
+8%
8 063
+13%
13 497
+67%
13 813
+2%
16 984
+23%
21 057
+24%
22 371
+6%
22 515
+1%
24 991
+11%
Liabilities
Accounts Payable
64
44
40
33
49
3
3
79
63
136
145
305
708
655
653
702
628
1 056
834
662
734
873
1 330
1 217
Accrued Liabilities
0
0
0
0
0
51
50
64
75
159
156
310
598
466
529
662
942
1 287
1 192
1 477
2 137
1 615
1 499
1 711
Short-Term Debt
0
1
8
25
10
22
14
0
0
0
0
0
0
12
0
0
0
285
0
60
7
2
2
2
Current Portion of Long-Term Debt
52
49
52
96
43
54
92
77
118
307
695
1 306
1 268
1 089
2 006
1 712
2 222
2 021
990
1 575
2 122
3 253
2 353
3 146
Other Current Liabilities
60
60
60
64
70
0
0
2
8
35
35
36
40
50
61
81
215
318
573
529
565
711
547
497
Total Current Liabilities
176
154
161
218
172
131
159
222
264
637
1 031
1 957
2 614
2 273
3 249
3 157
4 007
4 967
3 590
4 303
5 566
6 455
5 731
6 573
Long-Term Debt
0
2
78
0
0
0
0
195
150
40
37
116
404
668
1 179
1 211
769
320
1 075
814
1 523
1 222
1 052
1 297
Deferred Income Tax
0
0
0
0
2
2
0
45
43
68
83
81
50
59
144
189
196
179
172
182
198
220
222
300
Minority Interest
13
29
31
13
3
3
1
84
96
279
331
126
214
195
245
274
226
244
136
105
50
68
113
52
Other Liabilities
0
23
1
0
0
75
81
20
22
96
311
321
406
683
657
609
632
596
467
342
327
265
240
295
Total Liabilities
189
N/A
208
+10%
271
+30%
230
-15%
178
-23%
211
+19%
242
+15%
565
+133%
576
+2%
1 119
+94%
1 792
+60%
2 601
+45%
3 688
+42%
3 877
+5%
5 474
+41%
5 440
-1%
5 829
+7%
6 306
+8%
5 438
-14%
5 745
+6%
7 664
+33%
8 231
+7%
7 358
-11%
8 518
+16%
Equity
Common Stock
82
98
138
4
11
11
11
11
11
19
19
20
20
20
20
22
22
31
34
35
35
35
35
35
Retained Earnings
31
62
150
81
17
27
79
100
72
256
311
402
502
677
787
1 044
1 469
2 183
3 037
4 506
6 535
8 224
9 607
11 190
Additional Paid In Capital
208
220
224
25
94
94
94
94
94
269
269
282
282
282
282
661
661
5 052
5 511
6 523
6 523
6 523
6 523
6 523
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
6
3
3
0
0
0
0
0
1
1
12
3
99
279
341
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
144
187
269
269
Other Equity
70
70
70
70
69
69
69
0
0
18
37
46
74
135
71
24
82
76
208
163
440
355
460
666
Total Equity
189
N/A
186
-2%
142
-24%
40
-72%
19
-53%
9
-53%
43
N/A
5
N/A
33
+560%
568
+1 621%
639
+13%
753
+18%
877
+16%
1 113
+27%
1 160
+4%
1 702
+47%
2 234
+31%
7 191
+222%
8 375
+16%
11 240
+34%
13 393
+19%
14 140
+6%
15 158
+7%
16 473
+9%
Total Liabilities & Equity
377
N/A
394
+5%
414
+5%
270
-35%
197
-27%
220
+12%
199
-10%
570
+186%
609
+7%
1 687
+177%
2 431
+44%
3 354
+38%
4 565
+36%
4 991
+9%
6 633
+33%
7 142
+8%
8 063
+13%
13 497
+67%
13 813
+2%
16 984
+23%
21 057
+24%
22 371
+6%
22 515
+1%
24 991
+11%
Shares Outstanding
Common Shares Outstanding
43
51
72
374
1 121
1 121
1 121
1 121
1 121
1 931
1 931
1 973
1 973
1 973
1 973
2 249
2 249
3 135
3 378
3 550
3 550
3 519
3 502
3 502